W NEIL JONES Insider Trading $NOVN NOVEN PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for W NEIL JONES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of W NEIL JONES. W NEIL JONES is VP - Marketing & Sales in NOVEN PHARMACEUTICALS INC ($NOVN) and VP, Marketing & Sales in NOVEN PHARMACEUTICALS INC ($NOVN).
W NEIL JONES in NOVEN PHARMACEUTICALS INC
Trading Symbol: NOVNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of W NEIL JONES: VP - Marketing & Sales, VP, Marketing & Sales
Holdings: 2,512 shares
Current Value: $10,224
Latest Transaction: Nov 15 2007
$NOVN Market Capitalization: $65.66M
$NOVN Previous Close: $4.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of W NEIL JONES in NOVEN PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 15 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 14.54 | 44,709 | 650,069 | 44,709 | |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 6,609 | 99,994 | 0 | |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.90 | 6,609 | 171,173 | 2,512 | 9.1 K to 2.5 K (-72.46 %) |
Jun 21 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 6,609 | 99,994 | 9,121 | 2.5 K to 9.1 K (+263.10 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.68 | 7,716 | 105,555 | 23,148 | |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 1,391 | 21,046 | 6,609 | |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.90 | 7,716 | 192,128 | 2,512 | 10.2 K to 2.5 K (-75.44 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.68 | 7,716 | 105,555 | 10,228 | 2.5 K to 10.2 K (+307.17 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.90 | 1,391 | 34,636 | 2,512 | 3.9 K to 2.5 K (-35.64 %) |
Apr 16 2007 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 1,391 | 21,046 | 3,903 | 2.5 K to 3.9 K (+55.37 %) |
Nov 16 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 22.83 | 23,527 | 537,121 | 23,527 | |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 10,000 | 131,100 | 10,000 | |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.38 | 10,000 | 253,790 | 2,512 | 12.5 K to 2.5 K (-79.92 %) |
Sep 07 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.11 | 10,000 | 131,100 | 12,512 | 2.5 K to 12.5 K (+398.09 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.45 | 20,000 | 209,000 | 30,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 21,668 | 284,067 | 20,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 13.11 | 8,332 | 109,233 | 41,668 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 16,002 | 242,110 | 8,000 | |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.01 | 900 | 22,509 | 2,512 | 3.4 K to 2.5 K (-26.38 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.00 | 40,768 | 1,019,200 | 3,412 | 44.2 K to 3.4 K (-92.28 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.45 | 20,000 | 209,000 | 44,180 | 24.2 K to 44.2 K (+82.71 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.11 | 21,668 | 284,067 | 24,180 | 2.5 K to 24.2 K (+862.58 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.02 | 100 | 2,502 | 2,512 | 2.6 K to 2.5 K (-3.83 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 25.00 | 24,234 | 605,850 | 2,612 | 26.8 K to 2.6 K (-90.27 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 13.11 | 8,332 | 109,233 | 26,846 | 18.5 K to 26.8 K (+45.00 %) |
Aug 30 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 16,002 | 242,110 | 18,514 | 2.5 K to 18.5 K (+637.02 %) |
Mar 20 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.00 | 3,250 | 32,500 | 0 | |
Mar 20 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 17.01 | 3,250 | 55,283 | 2,512 | 5.8 K to 2.5 K (-56.40 %) |
Mar 20 2006 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.00 | 3,250 | 32,500 | 5,762 | 2.5 K to 5.8 K (+129.38 %) |
Nov 17 2005 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 13.68 | 30,864 | 422,220 | 30,864 | |
Nov 12 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP - Marketing & Sa ... | Option Exercise | A | 22.60 | 50,000 | 1,130,000 | 50,000 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 15,998 | 242,050 | 24,002 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.00 | 3,033 | 30,330 | 3,250 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.00 | 6,717 | 67,170 | 3,033 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.00 | 16,880 | 405,120 | 2,512 | 19.4 K to 2.5 K (-87.05 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.01 | 100 | 2,401 | 19,392 | 19.5 K to 19.4 K (-0.51 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.03 | 1,100 | 26,433 | 19,492 | 20.6 K to 19.5 K (-5.34 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.04 | 951 | 22,862 | 20,592 | 21.5 K to 20.6 K (-4.41 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 15,998 | 242,050 | 21,543 | 5.5 K to 21.5 K (+288.51 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.00 | 3,033 | 30,330 | 5,545 | 2.5 K to 5.5 K (+120.74 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.00 | 6,717 | 161,208 | 2,512 | 9.2 K to 2.5 K (-72.78 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.00 | 6,717 | 67,170 | 9,229 | 2.5 K to 9.2 K (+267.40 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 15.13 | 15,998 | 242,050 | 24,002 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.00 | 3,033 | 30,330 | 3,250 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 10.00 | 6,717 | 67,170 | 3,033 | |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.00 | 16,880 | 405,120 | 2,512 | 19.4 K to 2.5 K (-87.05 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.01 | 100 | 2,401 | 19,392 | 19.5 K to 19.4 K (-0.51 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.03 | 1,100 | 26,433 | 19,492 | 20.6 K to 19.5 K (-5.34 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.04 | 951 | 22,862 | 20,592 | 21.5 K to 20.6 K (-4.41 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 15.13 | 15,998 | 242,050 | 21,543 | 5.5 K to 21.5 K (+288.51 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.00 | 3,033 | 30,330 | 5,545 | 2.5 K to 5.5 K (+120.74 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 24.00 | 6,717 | 161,208 | 2,512 | 9.2 K to 2.5 K (-72.78 %) |
Mar 05 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 10.00 | 6,717 | 67,170 | 9,229 | 2.5 K to 9.2 K (+267.40 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 4.19 | 10,000 | 41,900 | 0 | |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 8.67 | 5,000 | 43,350 | 0 | |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | M | 8.13 | 20,000 | 162,600 | 0 | |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 23.00 | 15,000 | 345,000 | 2,512 | 17.5 K to 2.5 K (-85.66 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 22.35 | 10,000 | 223,500 | 17,512 | 27.5 K to 17.5 K (-36.35 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Sell | S | 22.20 | 10,000 | 222,000 | 27,512 | 37.5 K to 27.5 K (-26.66 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 4.19 | 10,000 | 41,900 | 37,512 | 27.5 K to 37.5 K (+36.35 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 8.67 | 5,000 | 43,350 | 27,512 | 22.5 K to 27.5 K (+22.21 %) |
Mar 02 2004 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Buy | M | 8.13 | 20,000 | 162,600 | 22,512 | 2.5 K to 22.5 K (+796.18 %) |
Nov 06 2003 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 10.45 | 50,000 | 522,500 | 50,000 | |
Nov 06 2003 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 10.45 | 50,000 | 522,500 | 50,000 | |
Nov 06 2003 | NOVN | NOVEN PHARMACEUTIC ... | JONES W NEIL | VP, Marketing & Sal ... | Option Exercise | A | 10.45 | 50,000 | 522,500 | 50,000 |
Page: 1